Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.65% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Vanguard Morningstar Mega Cap ETF
MGC
$10.4B
| $1.48M | ﹤0.01% |
7,500
-900
| -11% | -$169K |
|
|
SGMO
2077
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.48M | ﹤0.01% |
4,126,577
+1,528,600
| +59% | +$826K |
|
|
BHR
2078
Braemar Hotels & Resorts
BHR
$139M
| $1.48M | ﹤0.01% |
579,700
+40,100
| +7% | +$106K |
|
2079
NBT Bancorp
NBTB
$2.78B
| $1.48M | ﹤0.01% |
38,239
-56,500
| -60% | -$2.04M |
|
2080
Superior Group of Companies
SGC
$213M
| $1.47M | ﹤0.01% |
78,000
+50,800
| +187% | +$937K |
|
2081
LENSAR
LNSR
$102M
| $1.47M | ﹤0.01% |
327,045
-1,300
| -0.4% | -$5.01K |
|
|
RVNC
2082
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.47M | ﹤0.01% |
572,000
+198,300
| +53% | +$677K |
|
|
BORR
2083
Borr Drilling
BORR
$1.25B
| $1.47M | ﹤0.01% |
+227,800
| New | +$1.37M |
|
|
TECX
2084
Tectonic Therapeutic
TECX
$720M
| $1.47M | ﹤0.01% |
89,029
+15,015
| +20% | +$241K |
|
2085
Avantis US Equity ETF
AVUS
$14.4B
| $1.46M | ﹤0.01% |
16,200
-2,000
| -11% | -$177K |
|
2086
Energy Services of America
ESOA
$239M
| $1.46M | ﹤0.01% |
203,892
+23,192
| +13% | +$168K |
|
2087
Capital Group Core Equity ETF
CGUS
$11.9B
| $1.45M | ﹤0.01% |
45,000
-35,700
| -44% | -$1.11M |
|
2088
Methanex
MEOH
$4.17B
| $1.45M | ﹤0.01% |
30,026
-31,802
| -51% | -$1.58M |
|
2089
Pacer Developed Markets International Cash Cows 100 ETF
ICOW
$1.84B
| $1.45M | ﹤0.01% |
+47,700
| New | +$1.52M |
|
2090
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14.1B
| $1.45M | ﹤0.01% |
21,800
-14,100
| -39% | -$903K |
|
2091
Janus Henderson B-BBB CLO ETF
JBBB
$1.43B
| $1.45M | ﹤0.01% |
+29,400
| New | +$1.44M |
|
2092
Sypris Solutions
SYPR
$46.8M
| $1.44M | ﹤0.01% |
752,021
-24,000
| -3% | -$38K |
|
2093
CytomX Therapeutics
CTMX
$760M
| $1.44M | ﹤0.01% |
1,183,022
-49,778
| -4% | -$99.1K |
|
2094
Vanguard Russell 2000 ETF
VTWO
$17.5B
| $1.44M | ﹤0.01% |
+17,600
| New | +$1.44M |
|
2095
Biote Corp
BTMD
$40.7M
| $1.44M | ﹤0.01% |
193,077
+138,200
| +252% | +$852K |
|
2096
iMGP DBi Managed Futures Strategy ETF
DBMF
$4.2B
| $1.44M | ﹤0.01% |
+47,976
| New | +$1.42M |
|
2097
The GEO Group
GEO
$4.14B
| $1.44M | ﹤0.01% |
100,425
+78,225
| +352% | +$1.11M |
|
2098
OppFi
OPFI
$608M
| $1.44M | ﹤0.01% |
424,315
-119,258
| -22% | -$363K |
|
2099
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.4B
| $1.44M | ﹤0.01% |
18,400
-49,300
| -73% | -$3.73M |
|
2100
Franklin Bitcoin ETF
EZBC
$375M
| $1.43M | ﹤0.01% |
+41,200
| New | +$1.57M |
|
Similar funds
Jim Simons's Q2 2024 Portfolio in Review
As of Q2 2024, Jim Simons held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $4.49B in Q2 2024, closing 674 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Broadcom worth $472M.
- Jim Simons's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Jim Simons added most to Apple in Q2 2024, an estimated $244M increase.
- Jim Simons's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Jim Simons fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Jim Simons's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Jim Simons opened 463 new positions and closed 674 in Q2 2024.
- Jim Simons's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.